#ban2401

Top Pharma News of the Week – July 9th

All The Most Important Pharmaceutical News Stories Of The Week – July 2018 – Week #2 FDA Grants Priority Review to Merck’s Supplemental Biologics License Application for KEYTRUDA® (pembrolizumab) in Combination with Chemotherapy as First-Line Treatment for Metastatic Squamous Non-Small Cell Lung Cancer

July 2, 2018

Merck, known as MSD outside the United States and Canada, has announced that the…